Home 
Search our Site
Search our Site
| or source: | |
| Publication date | |
| from: . . to: . . | |
Long-term tamoxifen use increases risk of an aggressive, hard to treat type of second breast cancer
While long-term tamoxifen use among breast cancer survivors decreases their risk of developing the most common, less aggressive type of second breast cancer, such use is associated with a more than fo...
Studies and Analyses |
Read moreBreastfeeding reduces risk of breast cancer in women with a family history of the disease
"This is good news for women with a family history of breast cancer," says Alison Stuebe, assistant professor of obstetrics and gynecology at the University of North Carolina at Chapel Hill ...
Studies and Analyses | Read moreEstrogen-Dependent Switch Tempers Killing Activity of Immune Cells
The key player in this process is a cytotoxic T cell molecule which has been known for a long time and which scientists have named EBAG9. Cancer researchers Dr. Constantin Rüder and Dr. Armin Rehm tog...
Life Sciences | Read moreBreast cancer drug shows promise against serious infections
An FDA-approved drug used for preventing recurrence of breast cancer shows promise in fighting life-threatening fungal infections common in immune-compromised patients, such as infants born prematurel...
Health and Medicine | Read moreDACH1 a key protein for tumor suppression in ER+ breast cancer
DACH1, a cell fate determination factor protein, prevents cancer cell proliferation by repressing the function of estrogen receptorsƒnin breast cancer, the researchers found. However, they also found ...
Life Sciences | Read moreStudy identifies how tamoxifen stimulates uterine cell growth and cancer
The research is significant in helping determine why tamoxifen and other synthetic estrogens are linked to increased rates of endometriosis and uterine cancer, and identifies a pathway that could be t...
Studies and Analyses | Read moreA new take on growth factor signaling in tamoxifen resistance
Sherene Loi, from the Peter MacCallum Cancer Centre, Melbourne, worked with a team of Australian and Belgian researchers to investigate the differences between those estrogen receptor positive (ER+) c...
Studies and Analyses | Read moreWomen with BRCA mutation, or worry, most likely to undergo prophylactic mastectomy
Women at increased risk for breast cancer because of the genetic BRCA mutations are more likely to think a prophylactic mastectomy is the best way to reduce their risk for the disease, compared to oth...
Studies and Analyses | Read moreHWI scientist first in world to unravel structure of key breast cancer target enzyme
The molecular details of Aromatase, the key enzyme required for the body to make estrogen, are no longer a mystery thanks to the structural biology work done by the Ghosh lab at the Hauptman-Woodward ...
Life Sciences | Read moreNovel basis identified for tamoxifen failure
A team of researchers co-ordinated by Dr. Stephen Hiscox, from the Welsh School of Pharmacy at Cardiff University, investigated the selective oestrogen receptor modulator (SERM) tamoxifen on human bre...
Health and Medicine | Read moreHerbal Menopause Therapy a Good Fit for Breast Cancer Patients?
When it comes to understanding the effectiveness and safety of using herbal therapies with other drugs, much is unknown. Now, a University of Missouri researcher will study how black cohosh - an herba...
Health and Medicine | Read moreDeactivating a cancer growth promoter
"This kind of information provides a target for the production of drugs against cancer," said Dr. Bert O'Malley, chair of molecular and cellular biology at BCM. "One can already fi...
Life Sciences | Read moreJoining forces against cancer
“We are at a crucial moment in our fight against cancer,” said ESMO President Prof. Jose Baselga. “We have never before made so much progress in our fight to eradicate cancer as a cause of death, and ...
Health and Medicine | Read moreFirst comprehensive analysis of cancer incidence, mortality and survival combined reveals encouraging trends in Europe ...
The first research to look at recent trends in European cancer incidence, mortality and survival together has shown that cancer prevention and management in Europe is moving in the right direction. Ho...
Health and Medicine | Read moreTeam Discovers New Inhibitors Of Estrogen-Dependent Breast Cancer Cells
“This cell-based study is exciting because it suggests these compounds are likely to be effective in tumors that remain dependent on estrogen for growth but are resistant to current therapies,” said p...
Life Sciences | Read more
Topmore news & reports about:
Agricultural and Forestry Science | Architecture and Construction | Automotive Engineering | Business and Finance | Communications Media | Earth Sciences | Ecology, The Environment and Conservation | Health and Medicine | Information Technology | Interdisciplinary Research | Life Sciences | Machine Engineering | Materials Sciences | Medical Engineering | Physics and Astronomy | Power and Electrical Engineering | Process Engineering | Social Sciences | Studies and Analyses | Transportation and Logisticsmore news & reports from the category "special topics":
Awards Funding | Event News | Innovative Products | Science Education | Seminars Workshops | Statistics | Technology Offerings | Trade Fair NewsAdditional Sponsors | |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 | |
|  |
|
 |
 | |
 |
 |
 | |
 |
 |
 |
 |
 |  |
 |
|
 |
 |
 | |
 |
 |
 |
 |
 | |
 |
 |
 | |
  |
|
  | |
 |
 |
 | |
 |
 |
 | |
 |
 |
 | |
 | |
 | |
 |
|
 | |
 | |
 | |
 | |
 | |
B2B Search
Company / Organisation
Home 
About us 
Partner 
Contact 
Sitemap 
find and help 
Deutsch
Disclaimer
2000-2009 by innovations-report